Argenica Therapeutics Ltd (AGN)

Snapshot

AGN's Principal Activity is the research and development of a neuroprotective therapeutic drug.

Announcements

Corporate Overview

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date	Amount	Franking	Gross	Type	Payable
No dividends paid.

Show All

See Upcoming Dividends for all ASX companies.

Directors & Management

Name	Title	Since	Bio
Mr Terrence (Terry) Charles Budge	Non-Executive Director	Jan 2021	Mr Terrence (Terry) Charles Budge Non-Executive Director Mr Budge has experience in senior management and board roles. A long term banker he spent 25 years with National Australia Bank in senior executive roles before serving as Managing Director of Bankwest from 1997 to 2004. Since then he has had many non-executive director roles including Chancellor of Murdoch University from 2006 to 2013. Terry is currently a director or Tiller Rides. He is the Chair of Risk Committee.
Ms Elizabeth (Liddy) McCall	Non-Executive Director	Dec 2020	Ms Elizabeth (Liddy) McCall Non-Executive Director Ms McCall is co-founder of 3 biotechnology companies successfully achieving 3 FDA drug registrations and 1 FDA/CE Mark medical device approval. She is an inventor on patents granted in major jurisdictions translating novel G-protein coupled pharmacology into a therapeutic drug treatment currently in Phase 2 clinical trials. Liddy cofounded IIF venture capital fund, Yuuwa Capital LP, which is responsible for a portfolio of 6 companies commercializing biotechnology and IT innovation. Liddy has over 25 years of experience in senior Board and management roles including Adalta Ltd, iCeutica Inc group, Dimerix Bioscience Pty Ltd and iCetana Pty Ltd. Liddy was an Associate Director in the Corporate Advisory Group of Macquarie Bank and prior to that worked as a lawyer with a leading Australian law firm. Liddy is a non-executive director of the not-for profit Ear Science Institute Australia and also of Agworld Pty Ltd, Nexgen Plants Pty Ltd and The Tailor Made Spirits Company Limited. She is a member of Audit & Risk Committee.
Dr Samantha (Sam) South	Executive Director	Mar 2020	Dr Samantha (Sam) South Executive Director Dr South is currently the Senior Commercialisation Officer (Life Sciences) in the Research Development & Innovation office at The University of Western Australia (UWA) and has over 12 years' experience in technology transfer in medtech / biotech sector, at The University of Queensland (UQ), Queensland University of Technology and UWA. Sam has background in medical research at Weill Medical College at Cornell University (NY), UQ and The Garvan Institute in CNS research. She was also the Preclinical Manager at TetraQ, a preclinical contract organisation, specialising in central nervous system animal models. Sam was the UWA Director on UWA spin-out companies MiReven Pty Ltd, Eridan Technologies Pty Ltd and OncoRes Medical Pty Ltd and is currently a Director of Rage Biotech Pty Ltd. Sam is also WA Ausbiotech Committee Chair, part of the Ausmedtech National Advisory Group and the SBE Life Sciences Council.
Mr Geoffrey (Geoff) Richard Pocock	Non-Executive Chairman,Non-Executive Director	Nov 2019	Mr Geoffrey (Geoff) Richard Pocock Non-Executive Chairman,Non-Executive Director Mr Pocock has over 20 years experience across the commercialisation process. Geoff's experience has covered technical roles, executive management as well as significant corporate finance and strategy roles with a number of technology commercialisation ventures. Geoff is the Principal of Polaris Consulting (WA) Pty Ltd, a specialist boutique commercialisation strategy and corporate advisory business based in Western Australia. He is a member of Risk Committee.
Ms Emma Waldon	Chief Financial Officer,Company Secretary	N/A
Dr Liz Dallimore	Chief Executive Officer	N/A
Liz Dallimore	Chief Executive Officer	N/A

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
Samantha (Sam) South	30/06/2021	N/A	2,000,000	1,000,000	N/A
Geoffrey (Geoff) Pocock	30/06/2021	N/A	4,377,000	500,000	N/A
Terrence (Terry) Budge	30/06/2021	N/A	455,000	500,000	N/A
Elizabeth (Liddy) McCall	30/06/2021	N/A	125,000	500,000	N/A

Show All

Top 20 Shareholders

About the Data

Name	Shares	Capital
Oofy Prosser Pty Ltd <Drones Family A/C>	4,377,000	5.98%
University Of Western Australia	3,953,000	5.40%
Perron Institute For Neurological And Translational Science Ltd	3,550,000	4.85%
Shane Michael Colley <Fiery King Investment A/C>	2,000,000	2.73%
Arredo Pty Ltd	1,550,000	2.12%
Shane Hoehock Wee <Wee Family A/C>	1,544,000	2.11%
Litis Super Pty Ltd <Jde Litis Super Fund>	1,500,000	2.05%
Xcel Capital Pty Ltd	1,462,500	2.00%
Bruno Philip Meloni <Bruno Meloni Family A/C>	1,277,000	1.75%
Ga Skylight Berhad	1,250,000	1.71%
Ms Helen Margaret Sewell	1,225,000	1.67%
Mr Neville William Knuckey & Mrs Jacqueline Joy Knuckey <The Knuckey Family A/C>	1,072,000	1.47%
Busso Holdings Pty Ltd <Bew A/C>	1,025,000	1.40%
Pentek Holdings Pty Ltd <The J Litis Investment No.2 A/C>	785,000	1.07%
Hugh James Pilgrim <The Hjp Family A/C>	734,500	1.00%
Mr Paul Henri Veron & Mrs Julie Anne Veron <Dead Knick S/F A/C>	725,000	0.99%
Kdjama Co Pty Ltd <Blacker Services A/C>	655,750	0.90%
Quantamatics Pty Ltd	573,000	0.78%
Ms Chunyan Niu	500,000	0.68%
Mr Luke Daniel Ferguson	500,000	0.68%

Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month

Historical Data

Year	Closing Price	Last Trade
No Financial Year End data available

AGN Historical Price Data (CSV)

Up to 20 years of EOD share price history

Sign up to Download

You must be logged in to access this feature. Please sign up for free or login.